Page last updated: 2024-08-23

estetrol and Body Weight

estetrol has been researched along with Body Weight in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Apter, D; Beekman, L; Coelingh Bennink, HJT; Foidart, JM; Maillard, C; Mawet, M; Zimmerman, Y	1
Arnal, JF; Briaux, A; Cabou, C; Dupuis, M; Foidart, JM; Fontaine, C; Garcia, C; Lairez, O; Lenfant, F; Noirrit-Esclassan, E; Payrastre, B; Valéra, MC	1
Foidart, JM; Gerard, C; Munaut, C; Nisolle, M; Noel, A; Pequeux, C; Tskitishvili, E	1

Trials

1 trial(s) available for estetrol and Body Weight

Article	Year
Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2017, Volume: 22, Issue:4 Topics: Adolescent; Adult; Androstenes; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estetrol; Female; Finland; Humans; Intention to Treat Analysis; Mineralocorticoid Receptor Antagonists; Patient Satisfaction; Surveys and Questionnaires; Uterine Hemorrhage; Young Adult	2017

Article

Year

Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2017, Volume: 22, Issue:4

Topics: Adolescent; Adult; Androstenes; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estetrol; Female; Finland; Humans; Intention to Treat Analysis; Mineralocorticoid Receptor Antagonists; Patient Satisfaction; Surveys and Questionnaires; Uterine Hemorrhage; Young Adult

2017

Other Studies

2 other study(ies) available for estetrol and Body Weight

Article	Year
Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis. Molecular and cellular endocrinology, 2018, 12-05, Volume: 477 Topics: Animals; Arteries; Blood Coagulation; Body Weight; Cell Nucleus; Collagen; Disease Models, Animal; Estetrol; Estradiol; Estrogen Receptor alpha; Female; Hemorheology; Hemorrhage; Horses; Mice, Inbred C57BL; Organ Size; Platelet Count; Selective Estrogen Receptor Modulators; Uterus; Venous Thrombosis	2018
Estetrol attenuates neonatal hypoxic-ischemic brain injury. Experimental neurology, 2014, Volume: 261 Topics: Animals; Animals, Newborn; Body Temperature; Body Weight; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Doublecortin Protein; Estetrol; Hippocampus; Hydrogen Peroxide; Hypoxia-Ischemia, Brain; L-Lactate Dehydrogenase; Neurons; Neuroprotective Agents; Oxidants; Rats; Rats, Sprague-Dawley	2014

Article

Year

Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis.

Molecular and cellular endocrinology, 2018, 12-05, Volume: 477

Topics: Animals; Arteries; Blood Coagulation; Body Weight; Cell Nucleus; Collagen; Disease Models, Animal; Estetrol; Estradiol; Estrogen Receptor alpha; Female; Hemorheology; Hemorrhage; Horses; Mice, Inbred C57BL; Organ Size; Platelet Count; Selective Estrogen Receptor Modulators; Uterus; Venous Thrombosis

2018

Estetrol attenuates neonatal hypoxic-ischemic brain injury.

Experimental neurology, 2014, Volume: 261

Topics: Animals; Animals, Newborn; Body Temperature; Body Weight; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Doublecortin Protein; Estetrol; Hippocampus; Hydrogen Peroxide; Hypoxia-Ischemia, Brain; L-Lactate Dehydrogenase; Neurons; Neuroprotective Agents; Oxidants; Rats; Rats, Sprague-Dawley

2014